HighTower Advisors
DGX icon

HighTower Advisors’s Quest Diagnostics DGX Stock Holding History

HighTower Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$3K – 3333
2021
Q3 		$3K Buy
+10,000
New +$1.46M ﹤0.01% 3079

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

HighTower Advisors's DGX Position: Q2 2026 in Review

HighTower Advisors increased its Quest Diagnostics (DGX) stake by 13% in Q2 2026, buying an estimated $1.51M and bringing the position to 67,692 shares worth $14.3M. The position accounts for 0.01% of the portfolio, ranked #780.

HighTower Advisors first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • HighTower Advisors held 67,692 shares of Quest Diagnostics worth $14.3M as of Q2 2026.
  • HighTower Advisors bought 7,678 Quest Diagnostics shares in Q2 2026, an estimated $1.51M.
  • Quest Diagnostics made up 0.01% of HighTower Advisors's portfolio in Q2 2026, its #780 holding.
  • HighTower Advisors first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.